NCT03254680

Turmeric as Treatment in Epilepsy

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: NYU Langone Health · Academic / Other
• Sex: All
• Age: 1 Year – 70 Years
• Healthy volunteers: Not accepted

Summary

This is a single center open-label pilot clinical trial of patients 1-70 years of age with greater than 6 seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures. Twenty patients will be enrolled and treated with a stable dose of orally administered turmeric oil daily for 3 months. Patients and caregivers will be asked to keep a seizure diary logging all clinical events during the course of the study. Serum comprehensive metabolic panel, complete blood count with differential, and antiseizure medication levels, will be monitored at baseline, 1.5 months, and at the end of 3 months.

Conditions

• Epilepsy
• Dravet Syndrome
• Lennox-Gastaut Syndrome
• Tuberous Sclerosis
• Focal Seizures

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Turmeric	Twenty patients will be enrolled and treated with a stable dose of orally administered turmeric oil daily for 3 months.

Timeline

• Start date: 2018-03-01
• Primary completion: 2018-11-01
• Completion: 2018-11-01
• First posted: 2017-08-18
• Last updated: 2018-04-30

Locations

1 site across 1 country: United States